Literature DB >> 11784630

Shortage of vaccines during a yellow fever outbreak in Guinea.

N Nathan1, M Barry, M Van Herp, H Zeller.   

Abstract

A yellow fever epidemic erupted in Guinea in September, 2000. From Sept 4, 2000, to Jan 7, 2001, 688 instances of the disease and 225 deaths were reported. The diagnosis was laboratory confirmed by IgM detection in more than 40 patients. A mass vaccination campaign was limited by insufficient international stocks. After the epidemic in Guinea, the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control decided that 2 million doses of 17D yellow fever vaccine, being stored as part of a UNICEF stockpile, should be used only in response to outbreaks.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11784630     DOI: 10.1016/S0140-6736(01)07185-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Yellow Fever Immunizations: Indications and Risks.

Authors:  Mary E. Wilson; Lin H. Chen; Elizabeth D. Barnett
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

2.  Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008.

Authors:  Michael A Johansson; Neysarí Arana-Vizcarrondo; Brad J Biggerstaff; Nancy Gallagher; Nina Marano; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 3.  Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations.

Authors:  Eugene Lam; Amanda McCarthy; Muireann Brennan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Acute arboviral infections in Guinea, West Africa, 2006.

Authors:  Emily S Jentes; Jaimie Robinson; Barbara W Johnson; Ibrahima Conde; Yosse Sakouvougui; Jennifer Iverson; Shanna Beecher; M Alpha Bah; Fousseny Diakite; Mamadi Coulibaly; Daniel G Bausch; Juliet Bryan
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 5.  The development of global vaccine stockpiles.

Authors:  Catherine Yen; Terri B Hyde; Alejandro J Costa; Katya Fernandez; John S Tam; Stéphane Hugonnet; Anne M Huvos; Philippe Duclos; Vance J Dietz; Brenton T Burkholder
Journal:  Lancet Infect Dis       Date:  2015-02-06       Impact factor: 25.071

Review 6.  Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.

Authors:  Emma Rey-Jurado; Felipe Tapia; Natalia Muñoz-Durango; Margarita K Lay; Leandro J Carreño; Claudia A Riedel; Susan M Bueno; Yvonne Genzel; Alexis M Kalergis
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

7.  Strategies for Vaccine Prioritization and Mass Dispensing.

Authors:  Eva K Lee; Zhuonan L Li; Yifan K Liu; James LeDuc
Journal:  Vaccines (Basel)       Date:  2021-05-14

8.  Acute spotted fever rickettsiosis among febrile patients, Cameroon.

Authors:  Lucy M Ndip; Donald H Bouyer; Amelia P A Travassos Da Rosa; V P K Titanji; Robert B Tesh; David H Walker
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

9.  Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.

Authors:  Tini Garske; Maria D Van Kerkhove; Sergio Yactayo; Olivier Ronveaux; Rosamund F Lewis; J Erin Staples; William Perea; Neil M Ferguson
Journal:  PLoS Med       Date:  2014-05-06       Impact factor: 11.069

10.  Proliferation of Aedes aegypti in urban environments mediated by the availability of key aquatic habitats.

Authors:  André Barretto Bruno Wilke; Chalmers Vasquez; Augusto Carvajal; Johana Medina; Catherine Chase; Gabriel Cardenas; John-Paul Mutebi; William D Petrie; John C Beier
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.